Neil Mendhiratta

Neil Mendhiratta

Auto-generated profile, based on publicly available information

Neil Mendhiratta

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2021 in Cancer
Verified
Journal Article
Closed access
PDF file
GBGennady Bratslavsky
Gennady Bratslavsky
NMNeil Mendhiratta
Neil Mendhiratta
MDMichael Daneshvar
Michael Daneshvar
JBJames Brugarolas
James Brugarolas
MBMark Ball
Mark Ball
BSBrian Shuch
Brian Shuch

22 May 2025 in NEJM AI
Verified
Journal Article
Closed access
WAWilliam S. Azar
William S. Azar
DJDylan M. Junkin
Dylan M. Junkin
CHCharles Hesswani
Charles Hesswani
CKChristopher R. Koller
Christopher R. Koller
SPSahil H. Parikh
Sahil H. Parikh
PPPeter A. Pinto
Peter A. Pinto

1 April 2016 in Journal of Urology
Verified
Journal Article
Open access
PDF file
XMXiaosong Meng
Xiaosong Meng
NMNeil Mendhiratta
Neil Mendhiratta
ARAndrew B. Rosenkrantz
Andrew B. Rosenkrantz
PGPauline Guiffart
Pauline Guiffart
RHRichard Huang
Richard Huang
STSamir S. Taneja
Samir S. Taneja
Increasing evidence supports the use of MRI fusion targeted biopsy (MRF-TB) to improve the detection of clinically significant prostate cancer (PCa) while limiting over-detection of indolent disease. We explored the relationship of serum PSA level and the relative outcomes of SB and MRF-TB.

1 August 2026 in Urologic Oncology: Seminars and Original Investigations
Verified
Journal Article
Closed access
RARyan M. Antar
Ryan M. Antar
VXVincent Eric Xu
Vincent Eric Xu
WAWilliam S. Azar
William S. Azar
NMNeil Mendhiratta
Neil Mendhiratta
MWMichael Whalen
Michael Whalen